Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical Absenteeism and Premature Death in Spinal Muscular Atrophy in Sweden: A Population-Based Matched Register Study of People of Working Age.

Advances in therapy·2026
Same author

Estimating per-protocol effects in external comparator analyses using real-world data.

Journal of comparative effectiveness research·2025
Same author

Quantitative Bias Analysis for Single-Arm Trials With External Control Arms.

JAMA network open·2025
Same author

Why is target trial emulation not being used in health technology assessment real-world data submissions?

Journal of comparative effectiveness research·2024
Same author

Acceptability of Using Real-World Data to Estimate Relative Treatment Effects in Health Technology Assessments: Barriers and Future Steps.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2024
Same author

Quantitative bias analysis for external control arms using real-world data in clinical trials: a primer for clinical researchers.

Journal of comparative effectiveness research·2024

Related Experiment Video

Updated: Mar 22, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.6K

COPD exacerbations by disease severity in England.

Evie Merinopoulou1, Mireia Raluy-Callado1, Sreeram Ramagopalan1

  • 1Real-World Evidence, Evidera, UK.

International Journal of Chronic Obstructive Pulmonary Disease
|April 22, 2016
PubMed
Summary

Patients with severe Chronic Obstructive Pulmonary Disease (COPD) face significantly higher exacerbation and hospitalization rates. Improved COPD management can reduce exacerbations and healthcare use.

Keywords:
COPDEnglandGOLD 2013admissionsexacerbationresource use

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K

Related Experiment Videos

Last Updated: Mar 22, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

1.6K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.6K

Area of Science:

  • Pulmonary Medicine
  • Health Services Research

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) exacerbations accelerate disease progression and increase healthcare utilization.
  • The Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification stratifies COPD severity.

Purpose of the Study:

  • To quantify COPD exacerbation rates in England.
  • To assess healthcare resource utilization across different GOLD 2013 severity categories.

Main Methods:

  • Utilized Clinical Practice Research Datalink and Hospital Episode Statistics for COPD patients (≥40 years).
  • Classified patients into GOLD severity groups (A-D) based on spirometry, dyspnea scale, and prior exacerbations.
  • Tracked outcomes including exacerbation rates, general practitioner visits, and hospital admissions from 2011 to 2013.

Main Results:

  • The cohort (n=44,201) comprised GOLD A (33.8%), B (21.0%), C (18.1%), and D (27.0%).
  • Annual exacerbation rates increased with severity: 0.83/person-year (GOLD A) to 2.51/person-year (GOLD D).
  • Healthcare utilization, including GP visits and hospitalizations, rose significantly with COPD severity.

Conclusions:

  • GOLD D patients experienced nearly triple the exacerbations and hospitalizations compared to GOLD A patients.
  • Increased GP visits were also observed in more severe COPD categories.
  • Stabilizing disease progression through better management may reduce exacerbation frequency and healthcare resource utilization.